Landscapes / Targets

JAK3

6 drugs act on JAK3, in 19 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs6

DrugHow it worksCompanyStageNext dateDetails
Janus kinase inhibitor
Pfizer · Public PFE
Approved 2 Dec 2026soonPhase 3 trial completes
Tyrosine kinase inhibitor
Approved 11 Dec 2026soonPhase 2 trial completes
JAK inhibitor
Approved in the EU Jun 2027Phase 3 trial completes
JAK inhibitor
Approved in Japan 30 Nov 2027Phase 4 trial completes
—
Phase 2 30 Dec 2027Phase 2 trial completes
—
Eli Lilly · Public LLY
Phase 2 —

About this list

Checked
6 of 6 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow JAK3

Following is part of Solo: you see every change to JAK3 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in